David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...
The company's stock value has tanked before - it was once worth $1 billion.
The House passed legislation Tuesday reauthorizing two “critical” federal grant programs that could funnel hundreds of ...
On February 17, 2026, Superstring Capital Management reported selling 345,869 shares of Terns Pharmaceuticals (TERN 1.53%) in ...
This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR ...
Gov. Dan McKee has appointed William Tsonos to chair the Rhode Island Life Science Hub, replacing interim chair Stefan Pryor.
Bolton’s Jim Varney, 51, left the industrial design business to open a coffee roastery with his wife, Deanna, last year. The pair now, ...
The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...
Analyst Faisal Khurshid applauded Abivax's obefazimod, an oral drug developed to treat moderately to severely active ...
Sydney hedge fund Regal Partners Ltd. was dealt a fresh blow after Immutep Ltd., an Australian biotech company it backs, ...
Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.
Organizers say understanding the range of career paths available can open more opportunities for young professionals entering STEM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results